Bellevue Asset Management, LLC Twist Bioscience Corp Transaction History

Bellevue Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$38.58 - $83.27 $501 - $1,082	-13 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$75.47 - $135.88 $150 - $271	-2 Reduced 13.33%	13 $1,000
Q2 2021 Aug 09, 2021	SELL	$88.13 - $142.06 $88 - $142	-1 Reduced 6.25%	15 $2,000
Q1 2021 May 12, 2021	SELL	$105.48 - $207.97 $210 - $415	-2 Reduced 11.11%	16 $2,000
Q4 2020 Feb 11, 2021	BUY	$76.64 - $167.89 $1,379 - $3,022	18 New	18 $3,000

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.38B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.